Benefit of BM-MSC addition in core decompression in treatment of osteonecrosis of the femoral head
How to Cite
OrthoEvidence. Benefit of BM-MSC addition in core decompression in treatment of osteonecrosis of the femoral head. ACE Report. 2019;8(8):9. Available from: https://myorthoevidene.com/AceReport/Report/11950
Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysisInt J Surg. 2019 Jul 10;69:23-31
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
14 randomized controlled trials were included in this meta-analysis which sought to investigate the impact of autologous bone marrow-derived mesenchymal stem cell (MSC) administration alongside core decompression on outcomes in treatment of patients with osteonecrosis of the femoral head. Pooled analyses of pain scores from 6 months to 2 years, function from 1 to 2 years, and incidence of eventual...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE